MA42148A - Utilisation de prg4 pour améliorer l'acuité visuelle dynamique et les aberrations d'ordre supérieur - Google Patents
Utilisation de prg4 pour améliorer l'acuité visuelle dynamique et les aberrations d'ordre supérieurInfo
- Publication number
- MA42148A MA42148A MA042148A MA42148A MA42148A MA 42148 A MA42148 A MA 42148A MA 042148 A MA042148 A MA 042148A MA 42148 A MA42148 A MA 42148A MA 42148 A MA42148 A MA 42148A
- Authority
- MA
- Morocco
- Prior art keywords
- prg4
- higher order
- visual acuity
- order aberrations
- dynamic visual
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrane Compounds (AREA)
- Prostheses (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562163753P | 2015-05-19 | 2015-05-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA42148A true MA42148A (fr) | 2018-04-04 |
Family
ID=57320651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA042148A MA42148A (fr) | 2015-05-19 | 2016-05-19 | Utilisation de prg4 pour améliorer l'acuité visuelle dynamique et les aberrations d'ordre supérieur |
Country Status (14)
Country | Link |
---|---|
US (1) | US11666529B2 (fr) |
EP (1) | EP3300482B1 (fr) |
JP (2) | JP7291459B2 (fr) |
CY (1) | CY1124538T1 (fr) |
DK (1) | DK3300482T3 (fr) |
ES (1) | ES2893304T3 (fr) |
HR (1) | HRP20211589T1 (fr) |
HU (1) | HUE056409T2 (fr) |
LT (1) | LT3300482T (fr) |
MA (1) | MA42148A (fr) |
PL (1) | PL3300482T3 (fr) |
PT (1) | PT3300482T (fr) |
SI (1) | SI3300482T1 (fr) |
WO (1) | WO2016187414A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015060935A1 (fr) | 2013-10-22 | 2015-04-30 | Lubris, Llc | Régulation des propriétés rhéologiques de solutions de hyaluronate/lubricine mélangées |
EP3250221B1 (fr) | 2015-01-26 | 2020-05-27 | Lubris, Llc | Utilisation de prg4 comment agent anti-inflammatoire |
US20210260167A1 (en) * | 2018-06-21 | 2021-08-26 | Lubris Llc | Lubricin for use in wound healing |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6433142B1 (en) | 1989-08-08 | 2002-08-13 | Genetics Institute, Llc | Megakaryocyte stimulating factors |
US6743774B1 (en) | 1999-04-23 | 2004-06-01 | Rhode Island Hospital | Tribonectins |
US6960562B2 (en) | 1999-04-23 | 2005-11-01 | Rhode Island Hospital, A Lifespan Partner | Tribonectin polypeptides and uses thereof |
US7001881B1 (en) | 1999-04-23 | 2006-02-21 | Rhode Island Hospital | Tribonectins |
US7415381B2 (en) | 2003-01-09 | 2008-08-19 | Rhode Island Hospital, A Lifespan Partner | Joint friction sensing |
US20060240037A1 (en) | 2003-06-04 | 2006-10-26 | Edward Fey | Methods and compositions for the treatment and prevention of degenerative joint disorders |
US20090155200A1 (en) | 2004-04-20 | 2009-06-18 | Jay Gregory D | Methods of promoting cartilage healing or cartilage integration |
US20080287369A1 (en) | 2004-07-23 | 2008-11-20 | Jay Gregory D | Compositions and Methods for Viscosupplementation |
EP1827478A4 (fr) | 2004-12-03 | 2009-08-05 | Mucosal Therapeutics Llc | Methodes de traitement d'articulations lesees ou malades |
US20070111327A1 (en) | 2005-05-05 | 2007-05-17 | Jay Gregory D | Methods of detecting lubricin |
US8144631B2 (en) | 2006-12-13 | 2012-03-27 | Cisco Technology, Inc. | Interconnecting IP video endpoints with reduced H.320 call setup time |
WO2008143816A1 (fr) | 2007-05-15 | 2008-11-27 | Mucosal Therapeutics | Compositions et procédés pour la réduction de la friction entre la surface des tendons et d'autres tissus mous |
US20090068247A1 (en) | 2007-09-12 | 2009-03-12 | Mucosal Therapeutics | Biocompatible devices coated with a tribonectin and methods for their production |
US20090104148A1 (en) | 2007-09-18 | 2009-04-23 | Jay Gregory D | Treatment and prevention of joint disease |
US8506944B2 (en) | 2008-05-07 | 2013-08-13 | The Regents Of The University Of California | Replenishment and enrichment of ocular surface lubrication |
LT2915529T (lt) | 2008-05-07 | 2018-10-25 | The Regents Of The University Of California | Gydomasis akių paviršiaus sutepimo atstatymas ir praturtinimas |
ES2534082T3 (es) | 2009-01-13 | 2015-04-17 | Lubris Llc | Modulación terapéutica de la lubricación del límite del epitelio vaginal |
ES2532526T3 (es) | 2009-05-22 | 2015-03-27 | Lubris, Llc | Aplicación y usos de PRG4 y modulación terapéutica de la misma |
EP2464375B1 (fr) | 2009-08-13 | 2017-06-14 | Lubris LLC | Traitement de prg4 pour cystite interstitielle |
US11213566B2 (en) | 2010-01-19 | 2022-01-04 | Lubris Llc | Oral care compositions and methods |
PL2461767T3 (pl) | 2010-07-30 | 2013-09-30 | Novartis Ag | Soczewki silikonowo-hydrożelowe z powierzchniami bogatymi w wodę |
US9974685B2 (en) | 2011-08-29 | 2018-05-22 | Mati Therapeutics | Drug delivery system and methods of treating open angle glaucoma and ocular hypertension |
US20130116186A1 (en) | 2011-10-04 | 2013-05-09 | Rhode Island Hospital, A Lifespan Partner | Lubricin injections to maintain cartilage health |
WO2015060935A1 (fr) | 2013-10-22 | 2015-04-30 | Lubris, Llc | Régulation des propriétés rhéologiques de solutions de hyaluronate/lubricine mélangées |
EP3074022B1 (fr) | 2013-11-26 | 2022-03-30 | Lubris LLC | Compositions et procédés pour inhiber les interactions intercellulaires |
EP3250221B1 (fr) | 2015-01-26 | 2020-05-27 | Lubris, Llc | Utilisation de prg4 comment agent anti-inflammatoire |
US20180161393A1 (en) | 2015-01-26 | 2018-06-14 | Lubris Llc | Prg4 for treating gout and its symptoms |
US20170312335A1 (en) | 2015-12-30 | 2017-11-02 | Lubris Llc | Topical use of prg4 for treatment of allergy and symptoms of inflammation |
-
2016
- 2016-05-19 WO PCT/US2016/033248 patent/WO2016187414A1/fr active Application Filing
- 2016-05-19 HR HRP20211589TT patent/HRP20211589T1/hr unknown
- 2016-05-19 EP EP16797292.6A patent/EP3300482B1/fr active Active
- 2016-05-19 LT LTEPPCT/US2016/033248T patent/LT3300482T/lt unknown
- 2016-05-19 DK DK16797292.6T patent/DK3300482T3/da active
- 2016-05-19 PT PT16797292T patent/PT3300482T/pt unknown
- 2016-05-19 ES ES16797292T patent/ES2893304T3/es active Active
- 2016-05-19 JP JP2017559312A patent/JP7291459B2/ja active Active
- 2016-05-19 MA MA042148A patent/MA42148A/fr unknown
- 2016-05-19 SI SI201631361T patent/SI3300482T1/sl unknown
- 2016-05-19 US US15/574,712 patent/US11666529B2/en active Active
- 2016-05-19 HU HUE16797292A patent/HUE056409T2/hu unknown
- 2016-05-19 PL PL16797292T patent/PL3300482T3/pl unknown
-
2021
- 2021-06-16 JP JP2021099827A patent/JP2021167318A/ja active Pending
- 2021-10-05 CY CY20211100858T patent/CY1124538T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
HRP20211589T1 (hr) | 2022-01-07 |
PT3300482T (pt) | 2021-10-15 |
EP3300482A4 (fr) | 2019-02-13 |
JP7291459B2 (ja) | 2023-06-15 |
PL3300482T3 (pl) | 2022-01-03 |
US11666529B2 (en) | 2023-06-06 |
WO2016187414A1 (fr) | 2016-11-24 |
HUE056409T2 (hu) | 2022-02-28 |
LT3300482T (lt) | 2021-10-25 |
JP2021167318A (ja) | 2021-10-21 |
EP3300482A1 (fr) | 2018-04-04 |
JP2018515534A (ja) | 2018-06-14 |
CY1124538T1 (el) | 2022-07-22 |
EP3300482B1 (fr) | 2021-07-14 |
US20180140546A1 (en) | 2018-05-24 |
SI3300482T1 (sl) | 2021-11-30 |
ES2893304T3 (es) | 2022-02-08 |
DK3300482T3 (da) | 2021-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA43387A (fr) | Anticorps anti-gitr et leurs méthodes d'utilisation | |
MA44955A (fr) | Anticorps anti-tau et leurs méthodes d'utilisation | |
MA42243A (fr) | Anticorps de facteur xi et méthodes d'utilisation | |
MA40008A (fr) | Antagoniste actrii pour le traitement et la prevention d'un ulcere cutane chez un sujet ayant l'anemie | |
ITUB20152211A1 (it) | Dispositivo e metodo per separare la frazione solida dalla frazione liquida di una torbida | |
MA46963A (fr) | Méthodes pour déterminer le dosage de céllules car-t | |
FR3016371B1 (fr) | Levures modifiees pour utiliser le dioxyde de carbone | |
MA43361A (fr) | Composition pour le soin et la protection de cultures | |
MA54716A (fr) | Réduction de la viscosité de formulations pharmaceutiques | |
MA42118A (fr) | Benzamides substitués et leurs méthodes d'utilisation | |
FR2999428B1 (fr) | Chitine ou derives de chitine pour utilisation dans la prevention et/ou le traitement de parasitoses | |
MA53991A (fr) | Protéines de fusion de l'inhibiteur de la c1 estérase et leurs utilisations | |
MA50678A (fr) | Molécules de liaison spécifiques de l'il-21 et leurs utilisations | |
MA52644A (fr) | Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation | |
MA44968A (fr) | Esters d'oxaborole et leurs utilisations | |
FR2999191B1 (fr) | Souches probiotiques pour le traitement et/ou la prevention de la diarrhee | |
MA42148A (fr) | Utilisation de prg4 pour améliorer l'acuité visuelle dynamique et les aberrations d'ordre supérieur | |
DK3445331T3 (da) | Farmaceutiske oftalmiske sammensætninger uden konserveringsmidler | |
BR112017010940A2 (pt) | produto líquido de limpeza de pele | |
FR3039166B1 (fr) | Progeniteurs de megacaryocytes cd34+cd41dim et leurs utilisations pour produire des plaquettes et/ou des mk portant des proplaquettes | |
GB201702415D0 (en) | Improvements in or relating to optical devices | |
FR3025698B1 (fr) | Nouvelles utilisations d'esters carboniques de glycerol en agriculture | |
FR3020452B3 (fr) | Module d'etuvage et de conservation, en complement du module d'etuvage en continue | |
FR3017536B1 (fr) | Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase | |
MA43834A (fr) | Combinaison pour traiter la douleur |